Gene expression analysis of TIL rich HPV-driven head and neck tumors reveals a distinct B-cell signature when compared to HPV independent tumors.

Validation of Immune Cell Modules in Multicellular Transcriptomic Data. PLoS One (2017) 0.75

The Metalloproteinase ADAM28 Promotes Metabolic Dysfunction in Mice. Int J Mol Sci (2017) 0.75

Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors. Adv Anat Pathol (2017) 0.75

Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27

Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22

edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics (2009) 67.17

The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem (2009) 40.90

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science (2006) 24.54

HTSeq--a Python framework to work with high-throughput sequencing data. Bioinformatics (2014) 23.22

Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med (2010) 22.74

The mutational landscape of head and neck squamous cell carcinoma. Science (2011) 16.88

Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol (2011) 12.10

Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol (2008) 7.97

Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res (1988) 7.30

Individuality and variation in gene expression patterns in human blood. Proc Natl Acad Sci U S A (2003) 6.49

Head and neck cancer. Lancet (2008) 6.33

Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature (2015) 5.50

Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood (2010) 4.28

Molecular and genetic properties of tumors associated with local immune cytolytic activity. Cell (2015) 4.16

Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell (2004) 3.91

A HaemAtlas: characterizing gene expression in differentiated human blood cells. Blood (2009) 3.63

Cell-type specific gene expression profiles of leukocytes in human peripheral blood. BMC Genomics (2006) 3.27

Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers. Cancer Res (2007) 2.93

ConsensusPathDB: toward a more complete picture of cell biology. Nucleic Acids Res (2010) 2.79

Immune response in silico (IRIS): immune-specific genes identified from a compendium of microarray expression data. Genes Immun (2005) 2.69

Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers. Clin Cancer Res (2006) 2.56

CD200 and membrane protein interactions in the control of myeloid cells. Trends Immunol (2002) 2.45

The B-cell receptor signaling pathway as a therapeutic target in CLL. Blood (2012) 2.39

Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma. Clin Cancer Res (2006) 2.05

CD20+ B cells: the other tumor-infiltrating lymphocytes. J Immunol (2010) 1.95

Biomarkers of HPV in head and neck squamous cell carcinoma. Cancer Res (2012) 1.76

Mammalian STAG3 is a cohesin specific to sister chromatid arms in meiosis I. Nat Cell Biol (2001) 1.75

The role of human papillomavirus in the increased incidence of base of tongue cancer. Int J Cancer (2010) 1.69

B cells regulate macrophage phenotype and response to chemotherapy in squamous carcinomas. Cancer Cell (2014) 1.43

Biological and clinical relevance of transcriptionally active human papillomavirus (HPV) infection in oropharynx squamous cell carcinoma. Int J Cancer (2010) 1.33

The Ets protein Spi-B is expressed exclusively in B cells and T cells during development. J Exp Med (1996) 1.30

Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer. Br J Cancer (2013) 1.28

Interleukin 21-induced granzyme B-expressing B cells infiltrate tumors and regulate T cells. Cancer Res (2013) 1.27

T-B-cell entanglement and ICOSL-driven feed-forward regulation of germinal centre reaction. Nature (2014) 1.23

Engagement of the ICOS pathway markedly enhances efficacy of CTLA-4 blockade in cancer immunotherapy. J Exp Med (2014) 1.18

Single sample expression-anchored mechanisms predict survival in head and neck cancer. PLoS Comput Biol (2012) 1.16

Melanoma cells express ICOS ligand to promote the activation and expansion of T-regulatory cells. Cancer Res (2010) 1.14

CTen: a web-based platform for identifying enriched cell types from heterogeneous microarray data. BMC Genomics (2012) 1.10

edgeR for differential RNA-seq and ChIP-seq analysis: an application to stem cell biology. Methods Mol Biol (2014) 1.06

Spectral clustering of microarray data elucidates the roles of microenvironment remodeling and immune responses in survival of head and neck squamous cell carcinoma. J Clin Oncol (2010) 1.04

Systemic and local human papillomavirus 16-specific T-cell immunity in patients with head and neck cancer. Int J Cancer (2011) 1.03

Deconvoluting post-transplant immunity: cell subset-specific mapping reveals pathways for activation and expansion of memory T, monocytes and B cells. PLoS One (2010) 1.03

Tumor expression of CD200 inhibits IL-10 production by tumor-associated myeloid cells and prevents tumor immune evasion of CTL therapy. Eur J Immunol (2010) 1.00

Lymphoid follicles are generated in high-grade cervical dysplasia and have differing characteristics depending on HIV status. Am J Pathol (2002) 0.97

CD200R signaling in tumor tolerance and inflammation: A tricky balance. Curr Opin Immunol (2012) 0.95

CD200/CD200R paired potent inhibitory molecules regulating immune and inflammatory responses; Part I: CD200/CD200R structure, activation, and function. Acta Medica (Hradec Kralove) (2012) 0.95

Staging and treatment of oropharyngeal cancer in the human papillomavirus era. Head Neck (2014) 0.91

CD200-expressing human basal cell carcinoma cells initiate tumor growth. Proc Natl Acad Sci U S A (2013) 0.90

Immune cell infiltration patterns and survival in head and neck squamous cell carcinoma. Head Neck Oncol (2013) 0.86

p27 and BCL2 expression predicts response to chemotherapy in head and neck squamous cell carcinomas. Oral Oncol (2013) 0.83